Implementation of a Pharmacogenomic Service in a Pediatric Community Hospital.

An often overlooked yet increasingly important factor in selecting appropriate medication therapy is a patient's genetic makeup. The primary goal of implementing a pharmacogenomics program is to reduce the risk of adverse drug reactions and decrease the risk of therapeutic failures. With recent technological advances, decreased cost of testing, and availability of pharmacogenomic guidance, pre-emptive pharmacogenomic testing has become more accessible and practical. Our institution's initiative to implement a clinical pharmacogenomics program reflects a broader commitment to advancing personalized medicine. We outline the processes and strategies employed to implement a pharmacogenomics service within a free-standing pediatric community hospital, with a pilot program focused on pediatric oncology patients. Various factors must be considered when implementing a pharmacogenomics program not limited to gene identification, laboratory selection, and technology integration. As the field continues to advance, our experience highlights the importance of adaptability, continuous learning, and a patient-centered approach to maximize the benefits of personalized medicine in pediatric care.